Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Meleady

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nutrition Reviews|November 27, 1999
Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?R Meleady, I Graham
BMJ (Clinical Research Ed.)|December 7, 1996
Heart attacks and homocysteineI Graham, R Meleady
Irish Journal of Medical Science|June 25, 1998
The benefit of lowering cholesterol: relative risk can be absolutely misleading!R Meleady, I M Graham
European Heart Journal|September 27, 2002
Smoking and plasma homocysteineP O'Callaghan, R Meleady, T Fitzgerald, et al.
Biochemical Society Transactions|July 26, 2000
Investigation of methionine metabolism in peripheral blood mononuclear cells of Irish hyperhomocysteinemic subjectsV Betts, P B Collins, R Meleady, et al.
European Heart Journal|August 24, 1999
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC GroupP Verhoef, R Meleady, L E Daly, et al.
The British Journal of Ophthalmology|February 3, 2000
Raised plasma homocysteine as a risk factor for retinal vascular occlusive diseaseM Cahill, M Karabatzaki, R Meleady, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic strokeD L Harmon, R M Doyle, R Meleady, et al.
The British Journal of Ophthalmology|January 3, 2001
Thermolabile MTHFR genotype and retinal vascular occlusive diseaseM Cahill, M Karabatzaki, C Donoghue, et al.
Circulation|November 1, 1996
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutationP M Gallagher, R Meleady, D C Shields, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nutrition Reviews|November 27, 1999
Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?R Meleady, I Graham
BMJ (Clinical Research Ed.)|December 7, 1996
Heart attacks and homocysteineI Graham, R Meleady
Irish Journal of Medical Science|June 25, 1998
The benefit of lowering cholesterol: relative risk can be absolutely misleading!R Meleady, I M Graham
European Heart Journal|September 27, 2002
Smoking and plasma homocysteineP O'Callaghan, R Meleady, T Fitzgerald, et al.
Biochemical Society Transactions|July 26, 2000
Investigation of methionine metabolism in peripheral blood mononuclear cells of Irish hyperhomocysteinemic subjectsV Betts, P B Collins, R Meleady, et al.
European Heart Journal|August 24, 1999
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC GroupP Verhoef, R Meleady, L E Daly, et al.
The British Journal of Ophthalmology|February 3, 2000
Raised plasma homocysteine as a risk factor for retinal vascular occlusive diseaseM Cahill, M Karabatzaki, R Meleady, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic strokeD L Harmon, R M Doyle, R Meleady, et al.
The British Journal of Ophthalmology|January 3, 2001
Thermolabile MTHFR genotype and retinal vascular occlusive diseaseM Cahill, M Karabatzaki, C Donoghue, et al.
Circulation|November 1, 1996
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutationP M Gallagher, R Meleady, D C Shields, et al.
Pageof 2